GMP

ACROBiosystems launches GM-grade DLL4 Protein to accelerate stem cell manufacturing

Retrieved on: 
Thursday, November 16, 2023
Mycoplasma, IND, Uncertainty, Fibroblast, Growth, B cell, Risk, DLL4, Research, Safety, GMP, Virus, A-DNA, Quality assurance, Vaccine

The availability of DLL4 manufactured under GMP conditions represents a significant milestone for enterprises engaged in developing or manufacturing stem-cell based biologics.

Key Points: 
  • The availability of DLL4 manufactured under GMP conditions represents a significant milestone for enterprises engaged in developing or manufacturing stem-cell based biologics.
  • The GMP process guarantees that the DLL4 recombinant protein is consistent, contaminant-free, and developed in a controlled production environment for use as a raw material in stem cell culturing.
  • Conventionally, feeder cells such as OP9-DLL4 are employed to secrete DLL4 during the growth and differentiation of stem cells in vitro.
  • As such, these feeder cells are often utilized to stem cell research and develop potential therapies.

e2e Pharma Realizes the Benefits of InstantGMP PRO™ All-In-One Software

Retrieved on: 
Wednesday, November 15, 2023
GMP, Education, SOP, Equipment, Good manufacturing practice, Beauty, Clinical Global Impression, CMOS, MPR, Health, Cosmetics, PRO, BPR, Software, CMO, Communication, Contract manufacturing organization, Good, Fine chemical, Medical device, Warehouse, Asset management, Risk management

CARY, N.C., Nov. 15, 2023 /PRNewswire-PRWeb/ -- InstantGMP™, the industry frontrunner in electronic batch record, quality management, and inventory management software solutions, proudly commemorates two years of support to e2e Pharma, a distinguished Arizona-based Contract Manufacturing Organization (CMO).

Key Points: 
  • A leader in white-label and private-label contract manufacturing across diverse industries, including health, wellness, beauty, cosmetics, and pet products, e2e Pharma continues to benefit immensely from the innovative InstantGMP PRO™ software system.
  • With InstantGMP PRO, e2e Pharma and similar CMOs can improve their manufacturing processes and overall customer experience.
  • Key Benefits of InstantGMP PRO for e2e Pharma and Similar CMOs:
    Streamlined MPR, BPR, and SOP Creation: InstantGMP PRO simplifies the creation of Master Production Records (MPR), Batch Production Records (BPR), and Standard Operating Procedures (SOP).
  • InstantGMP takes immense pride in supporting e2e Pharma's operational excellence by implementing our all-in-one manufacturing, inventory, and quality system.

Wyeth Becomes the First Multinational Company to Launch an HMO Growing-Up Infant Formula in China

Retrieved on: 
Tuesday, November 14, 2023
Infant, Research, GMP, Breast milk, National Health Commission, Urinary tract infection, Risk, Food, HMO, Formula, Health maintenance organization, Nestlé Wyeth Nutrition, Nutrient, Lactose, R, Growth, Intake, Bronchitis

SUZHOU, China, Nov. 14, 2023 /PRNewswire/ -- On November 13th, 2023, Wyeth Nutrition announced the launch of its first illuma HMO Growing-up infant formula added with two human milk oligosaccharides (HMOs) in China.

Key Points: 
  • SUZHOU, China, Nov. 14, 2023 /PRNewswire/ -- On November 13th, 2023, Wyeth Nutrition announced the launch of its first illuma HMO Growing-up infant formula added with two human milk oligosaccharides (HMOs) in China.
  • Illuma is now the first international company to introduce an HMO infant formula in China.
  • [2]
    Wyeth Nutrition's long-term dedication and solid research foundation in this area allowed them to become the first foreign company to launch this innovative product in China.
  • The launch of the illuma HMO Growing-up Formula demonstrates Wyeth Nutrition's "in China, for China" commitment in addition to showcasing the company's overall strength.

Wyeth Becomes the First Multinational Company to Launch an HMO Growing-Up Infant Formula in China

Retrieved on: 
Tuesday, November 14, 2023
Infant, Research, GMP, Breast milk, National Health Commission, Urinary tract infection, Risk, Multimedia, Food, HMO, Formula, Health maintenance organization, Nestlé Wyeth Nutrition, Nutrient, Lactose, R, Growth, Intake, Bronchitis

SUZHOU, China, Nov. 14, 2023 /PRNewswire/ -- On November 13th, 2023, Wyeth Nutrition announced the launch of its first illuma HMO Growing-up infant formula added with two human milk oligosaccharides (HMOs) in China.

Key Points: 
  • SUZHOU, China, Nov. 14, 2023 /PRNewswire/ -- On November 13th, 2023, Wyeth Nutrition announced the launch of its first illuma HMO Growing-up infant formula added with two human milk oligosaccharides (HMOs) in China.
  • Illuma is now the first international company to introduce an HMO infant formula in China.
  • [2]
    Wyeth Nutrition's long-term dedication and solid research foundation in this area allowed them to become the first foreign company to launch this innovative product in China.
  • The launch of the illuma HMO Growing-up Formula demonstrates Wyeth Nutrition's "in China, for China" commitment in addition to showcasing the company's overall strength.

AQUALITAS LEADS THE WAY AS THE FIRST ORGANIC CANNABIS PRODUCER IN THE WORLD TO BE ISSUED EU-GMP CERTIFICATION AND A HEALTH CANADA DRUG ESTABLISHMENT LICENSE

Retrieved on: 
Tuesday, November 14, 2023
Health Canada, Research, GMP, Food, Providence, DEL, Certification, Science

After rigorous inspections, these accreditations confirm compliance with the highest industry manufacturing standards in the world for the production of cannabis products and active pharmaceutical ingredients.

Key Points: 
  • After rigorous inspections, these accreditations confirm compliance with the highest industry manufacturing standards in the world for the production of cannabis products and active pharmaceutical ingredients.
  • Aqualitas' primary processes, with respect to flower cultivation, finished packaging and extraction are all now conducted under GMP standards.
  • The EU-GMP Certification adds to Aqualitas' suite of production certifications which include IMC-Good Agricultural Practices (IMC-GAP), GAcP, and Clean Green Certifiied® status.
  • It will also enable expansion of their research collaborations and support their drug master file for projects in the USA.

Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety

Retrieved on: 
Monday, November 13, 2023
GMP, Publication, Patient safety, Cryptocurrency

The two papers that have been released are "Quality Elements for Suppliers of Products or Services to GMP Regulated Companies" and the "Managing of Critical Vendors (Version 2.0)".

Key Points: 
  • The two papers that have been released are "Quality Elements for Suppliers of Products or Services to GMP Regulated Companies" and the "Managing of Critical Vendors (Version 2.0)".
  • Jim Fries, CEO of Rx-360 commented, "Being able to watch industry peers work together to develop and launch best practice publications is very humbling.
  • We all know that patient safety is of the utmost importance when it comes to the development and commercialization of pharmaceutical products and these two papers show the commitment of the industry to supply chain integrity."
  • The two papers focus on topics such as identifying critical vendors, risk evaluation, analyzing data integrity, and ten key principles of GMP.

Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety

Retrieved on: 
Monday, November 13, 2023
GMP, Publication, Patient safety, Cryptocurrency

The two papers that have been released are "Quality Elements for Suppliers of Products or Services to GMP Regulated Companies" and the "Managing of Critical Vendors (Version 2.0)".

Key Points: 
  • The two papers that have been released are "Quality Elements for Suppliers of Products or Services to GMP Regulated Companies" and the "Managing of Critical Vendors (Version 2.0)".
  • Jim Fries, CEO of Rx-360 commented, "Being able to watch industry peers work together to develop and launch best practice publications is very humbling.
  • We all know that patient safety is of the utmost importance when it comes to the development and commercialization of pharmaceutical products and these two papers show the commitment of the industry to supply chain integrity."
  • The two papers focus on topics such as identifying critical vendors, risk evaluation, analyzing data integrity, and ten key principles of GMP.

One of Nation's Largest, Family-Owned Paper and Packaging Companies to Relocate

Retrieved on: 
Monday, November 13, 2023
Growth, BNSF, Certification, Paper, GMP, Good manufacturing practice, Drug, Warehouse

NORTHLAKE, Ill., Nov. 13, 2023 /PRNewswire-PRWeb/ -- Norkol Converting Corporation, one of the largest family-owned paper and packaging providers in the nation, announced today that it is relocating to a new facility in Montgomery, Illinois.

Key Points: 
  • Norkol Converting Corporation, one of the largest family-owned paper and packaging providers in the nation, announced today that it is relocating to a new facility in Montgomery, Illinois.
  • NORTHLAKE, Ill., Nov. 13, 2023 /PRNewswire-PRWeb/ -- Norkol Converting Corporation, one of the largest family-owned paper and packaging providers in the nation, announced today that it is relocating to a new facility in Montgomery, Illinois.
  • "Over the past several years, we have transformed our business model to better serve paper and packaging mills in reaching their Midwest customers.
  • For specific questions or concerns about the move, please contact your sales rep or call us at 708-531-1000.

Molecular Designs releases their new Candida auris PCR Simplicity Panel™

Retrieved on: 
Thursday, November 9, 2023
Simplicity, Research, GMP, Candida auris, Immunodeficiency, Patient, RT-PCR, Molecular design software, PCR, ISO, Laboratory, Workflow, Infection, Health care, Hospital, Vaccine, Candida

BIRMINGHAM, Ala., Nov. 9, 2023 /PRNewswire/ -- Molecular Designs, a leading provider of molecular infectious disease assays, has released its latest product, the Candida auris Simplicity Panel™.

Key Points: 
  • BIRMINGHAM, Ala., Nov. 9, 2023 /PRNewswire/ -- Molecular Designs, a leading provider of molecular infectious disease assays, has released its latest product, the Candida auris Simplicity Panel™.
  • It aims to improve the workflow for clinical and research laboratories with the advances they've achieved with their Simplicity Panel ™ technology.
  • The Candida auris Simplicity Panel™ is an in-vitro multiplex real-time polymerase chain reaction (RT-PCR) assay for qualitatively identifying this fungal pathogen.
  • In so doing, Molecular Designs aims to help laboratories respond to the challenge posed by Candida auris.

EQS-News: EVOMEDIS Announces Strategic Partnership with Medical University of Graz and COREMED Graz to Foster Wound Healing Innovation

Retrieved on: 
Thursday, December 7, 2023
Burns, Medical school, Regenerative medicine, Orphan, Atakent (business cooperation center), Partnership, European Medicines Agency, Transfusion medicine, ATMP, RESEARCH, Serology, Wound healing, GMP, Pharmaceutical industry, Nursing, Austria, Germany

Investing in the future of burn medicine: Alliance to develop new cell-based therapy

Key Points: 
  • Investing in the future of burn medicine: Alliance to develop new cell-based therapy
    Graz, Austria, 23 November 2023 – EVOMEDIS GmbH (EVOMEDIS), an R&D stage life science company developing next-generation wound healing solutions, today announced the initiation of a strategic partnership with the Medical University of Graz (MedUni) and COREMED (Cooperative Center for Regenerative Medicine / JOANNEUM RESEARCH Forschungsgesellschaft mbH) to propel the shift from wound care to wound healing through innovative solutions.
  • EVOMEDIS has pledged an investment of €1.5 million over a span of two years for a collaborative project.
  • We have set up our operations at MedUni, which is part of the Medical Science City Graz (MSCG).
  • This perfectly aligns with our strategy of working closely with local partners to develop new innovations for wound healing up to clinical proof-of-concept.